obesity Archives -

Price cut leads NICE to back Novo Nordisk’s obesity drug Saxenda

https://pharmaphorum.com/news/price-cut-leads-nice-to-back-novo-nordisks-obesity-drug-saxenda/

Merck & Co to repurpose failed obesity drug for NASH

https://pharmaphorum.com/news/merck-co-to-repurpose-failed-obesity-drug-for-nash/

Could GLP-1 drugs treat space headaches? NASA wants to know.

https://pharmaphorum.com/news/nasa-looks-on-as-uk-researchers-test-glp-1-drugs-against-space-headaches/

Rhythm doesn’t miss a beat as obesity drug clears phase 3 test

https://pharmaphorum.com/news/rhythm-doesnt-miss-a-beat-as-obesity-drug-clears-phase-3-test/

Boehringer adds to obesity alliance with Denmark’s Gubra

https://pharmaphorum.com/news/boehringer-obesity-denmarks-gubra/

FDA approves PureTech’s obesity device Plenity

https://pharmaphorum.com/news/fda-approves-puretech-obesity-plenity/

Can pharma halt the world’s obesity crisis?

https://pharmaphorum.com/views-and-analysis/can-pharma-halt-the-worlds-obesity-crisis/

Tackling obesity with a new therapeutic target

https://pharmaphorum.com/r-d/views-analysis-r-d/tackling-obesity-new-therapeutic-target/

England’s diabetes prevention success: patients shed weight of 15 double cheeseburgers

https://pharmaphorum.com/news/englands-diabetes-prevention-success-patients-shed-weight-15-double-cheeseburgers/

Search